Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Charles P Hart
Enhancement of Hypoxia-Activated Prodrug TH-302 Anti-Tumor Activity by Chk1 Inhibition
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Evaluation of the “Steal” Phenomenon on the Efficacy of Hypoxia Activated Prodrug TH-302 in Pancreatic Cancer
PLoS ONE
Multidisciplinary
Imaging Biomarkers to Monitor Response to the Hypoxia-Activated Prodrug TH-302 in the MiaPaCa2 Flank Xenograft Model
Magnetic Resonance Imaging
Nuclear Medicine
Radiology
Biomedical Engineering
Imaging
Biophysics
Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
Cancer Research
Cancer Research
Oncology
Scoparone Exerts Anti-Tumor Activity Against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity
PLoS ONE
Multidisciplinary
Combined Inhibition of Chk1 and Wee1: In Vitro Synergistic Effect Translates to Tumor Growth Inhibition in Vivo
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Rottlerin Exerts Its Anti-Tumor Activity Through Inhibition of Skp2 in Breast Cancer Cells
Oncotarget
Oncology
821 Anti-Tumor Activity Induced by Topical Delivery of HSP70iQ435A
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
The Unidirectional Hypoxia-Activated Prodrug OCT1002 Inhibits Growth and Vascular Development in Castrate-Resistant Prostate Tumors
Prostate
Oncology
Urology
Engineering a Prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy
Science Translational Medicine
Medicine
